Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
IsraelRecruiting
Conditions
Type1diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Soroka Medical Center, Beersheba, Israel
Contact: Study coordinator (Eli Hershkovitz, Prof)Rambam Medical Center, Haifa, Israel
Contact: Study coordinator (Naim Shehadeh, Prof)Hadassah medical Center, Jerusalem, Israel
Contact: Study coordinator (David Zangen, Dr)Child Health Centers all over Israel (clalit Health Services), Petah Tikva, Israel
Contact: Study coordinator (Avner Cohen, Prof)Schneider Children Medical Center of Israel, Petah Tikva, Israel
Contact: Study coordinator (Moshe Phillip, Prof)Contact: Study coordinator (Tal Oron, Dr.)Sheba Medical Center, Ramat Gan, Israel
Contact: Study coordinator (Orit Hamiel, Prof)Dana-Duek children's hospital, Tel Aviv, Israel
Contact: Study coordinator (Yael Lebenthal, Prof)
Study leads
Moshe Phillip, Prof
Study Director
Schneider Children's Medical Center